Literature DB >> 15027878

N,N-dialkyl-2-phenylindol-3-ylglyoxylamides. A new class of potent and selective ligands at the peripheral benzodiazepine receptor.

Giampaolo Primofiore1, Federico Da Settimo, Sabrina Taliani, Francesca Simorini, Maria Paola Patrizi, Ettore Novellino, Giovanni Greco, Enrico Abignente, Barbara Costa, Beatrice Chelli, Claudia Martini.   

Abstract

We report the synthesis and the affinity data at both the peripheral (PBR) and the central benzodiazepine receptors of a series of N,N-dialkyl-2-phenylindol-3-ylglyoxylamide derivatives III, designed as conformationally constrained analogues of 2-phenylindole-3-acetamides II such as FGIN-1-27. Most of the new compounds showed a high specificity and affinity for PBR, with K(i) in the nanomolar to subnanomolar range. The most potent ligands (4-7, 9, 13-27) stimulated steroid biosynthesis in rat C6 glioma cells with a potency similar to or higher than that of classical ligands. The SARs of this new class of compounds are discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15027878     DOI: 10.1021/jm030973k

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  14 in total

1.  Evaluation of novel N1-methyl-2-phenylindol-3-ylglyoxylamides as a new chemotype of 18 kDa translocator protein-selective ligand suitable for the development of positron emission tomography radioligands.

Authors:  Victor W Pike; Sabrina Taliani; Talakad G Lohith; David R J Owen; Isabella Pugliesi; Eleonora Da Pozzo; Jinsoo Hong; Sami S Zoghbi; Roger N Gunn; Christine A Parker; Eugenii A Rabiner; Masahiro Fujita; Robert B Innis; Claudia Martini; Federico Da Settimo
Journal:  J Med Chem       Date:  2010-12-06       Impact factor: 7.446

2.  N-(4-cyanotetrahydro-2H-pyran-4-yl) and N-(1-cyanocyclohexyl) derivatives of 1,5-diarylpyrazole-3-carboxamides showing high affinity for 18 kDa translocator protein and/or cannabinoid receptors.

Authors:  Sean R Donohue; Robert F Dannals; Christer Halldin; Victor W Pike
Journal:  J Med Chem       Date:  2011-03-23       Impact factor: 7.446

Review 3.  Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders.

Authors:  Rainer Rupprecht; Vassilios Papadopoulos; Gerhard Rammes; Thomas C Baghai; Jinjiang Fan; Nagaraju Akula; Ghislaine Groyer; David Adams; Michael Schumacher
Journal:  Nat Rev Drug Discov       Date:  2010-12       Impact factor: 84.694

4.  Translocator protein ligands based on N-methyl-(quinolin-4-yl)oxypropanamides with properties suitable for PET radioligand development.

Authors:  Chad Brouwer; Kimberly J Jenko; Sami S Zoghbi; Cheryl L Morse; Robert B Innis; Victor W Pike
Journal:  Eur J Med Chem       Date:  2016-08-25       Impact factor: 6.514

Review 5.  Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers.

Authors:  Fabien Chauveau; Hervé Boutin; Nadja Van Camp; Frédéric Dollé; Bertrand Tavitian
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-10-01       Impact factor: 9.236

6.  Solution structures of the prototypical 18 kDa translocator protein ligand, PK 11195, elucidated with 1H/13C NMR spectroscopy and quantum chemistry.

Authors:  Yong-Sok Lee; Fabrice G Siméon; Emmanuelle Briard; Victor W Pike
Journal:  ACS Chem Neurosci       Date:  2012-02-14       Impact factor: 4.418

7.  Apoptosis therapy in cancer: the first single-molecule co-activating p53 and the translocator protein in glioblastoma.

Authors:  Simona Daniele; Sabrina Taliani; Eleonora Da Pozzo; Chiara Giacomelli; Barbara Costa; Maria Letizia Trincavelli; Leonardo Rossi; Valeria La Pietra; Elisabetta Barresi; Alfonso Carotenuto; Antonio Limatola; Anna Lamberti; Luciana Marinelli; Ettore Novellino; Federico Da Settimo; Claudia Martini
Journal:  Sci Rep       Date:  2014-04-23       Impact factor: 4.379

8.  TSPO ligand residence time: a new parameter to predict compound neurosteroidogenic efficacy.

Authors:  Barbara Costa; Eleonora Da Pozzo; Chiara Giacomelli; Elisabetta Barresi; Sabrina Taliani; Federico Da Settimo; Claudia Martini
Journal:  Sci Rep       Date:  2016-01-11       Impact factor: 4.379

9.  Synthesis and pharmacological evaluation of [18F]PBR316: a novel PET ligand targeting the translocator protein 18 kDa (TSPO) with low binding sensitivity to human single nucleotide polymorphism rs6971.

Authors:  Filomena Mattner; Andrew Katsifis; Thomas Bourdier; Christian Loc'h; Paula Berghofer; Christopher Fookes; Tzong-Tyng Hung; Timothy Jackson; David Henderson; Tien Pham; Brendan J Lee; Rachael Shepherd; Ivan Greguric; Naomi Wyatt; Thanh Le; Jackson Poon; Carl Power; Michael Fulham
Journal:  RSC Med Chem       Date:  2021-04-19

Review 10.  NBD-based synthetic probes for sensing small molecules and proteins: design, sensing mechanisms and biological applications.

Authors:  Chenyang Jiang; Haojie Huang; Xueying Kang; Liu Yang; Zhen Xi; Hongyan Sun; Michael D Pluth; Long Yi
Journal:  Chem Soc Rev       Date:  2021-07-05       Impact factor: 60.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.